Potentiation of the Bronchoprotective Effects of Vasoactive Intestinal Peptide, Isoprenaline, and Theophylline Against Histamine Challenge in Anaesthetised Guinea Pigs by Adrenomedullin

Overview

Journal Thorax

Date 1996 Dec 1

PMID 8994515

Citations 1

Authors

H Kanazawa

T Kawaguchi

T Fujii

S Shoji

K Hirata

S Kudoh

N Kurihara

J Yoshikawa

Affiliations

Soon will be listed here.

Abstract

Background: Adrenomedullin is a hypotensive peptide recently discovered in human phaeochromocytoma which has been found to inhibit bronchoconstriction induced by histamine and acetylcholine. This study was designed to determine the manner in which adrenomedullin and other bronchodilators interact in modulating airway function.

Methods: A study was undertaken to determine whether adrenomedullin potentiated the bronchoprotective effects of isoprenaline, vasoactive intestinal peptide (VIP), and theophylline against histamine-induced bronchoconstriction in anaesthetised guinea pigs in vivo.

Results: Adrenomedullin in a concentration of 10(-9) M significantly inhibited histamine-induced bronchoconstriction but in a concentration of 10(-10) M it did not exhibit the bronchoprotective effect against histamine. VIP (10(-9) M) did not affect histamine-induced bronchoconstriction but it markedly inhibited the bronchoprotective effect against histamine in the presence of adrenomedullin (10(-10) M). VIP (10(-6) M) significantly inhibited histamine-induced bronchoconstriction but this effect was short lived. Adrenomedullin in a concentration of 10(-10) M potentiated bronchoprotection induced by VIP (10(-6) M) and prolonged it. Isoprenaline (10(-8) M) also significantly inhibited histamine-induced bronchoconstriction and this effect was enhanced in the presence of adrenomedullin (10(-10) M). Similarly, adrenomedullin (10(-10) M) significantly potentiated theophylline-induced bronchoprotection, and a sub-bronchoprotective dose of theophylline (20 mg/kg i.p.) was effective in preventing histamine-induced bronchoconstriction in the presence of adrenomedullin (10(-10) M).

Conclusions: This study shows that adrenomedullin potentiates the bronchoprotective effects of different classes of bronchodilators against histamine challenge in anaesthetised guinea pigs.

Citing Articles

VIP/PACAP signaling as an alternative target during hyperoxic exposure in preterm newborns.

Thaci Q, Recica S, Kryeziu I, Mitrokhin V, Kamkin A, Sopi R Physiol Res. 2021; 70(4):489-499.

PMID: 34062074 PMC: 8820544. DOI: 10.33549/physiolres.934638.

References

Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H . Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun. 1993; 192(2):553-60. DOI: 10.1006/bbrc.1993.1451. View

de Boer J, Philpott A, van Amsterdam R, Shahid M, Zaagsma J, Nicholson C . Human bronchial cyclic nucleotide phosphodiesterase isoenzymes: biochemical and pharmacological analysis using selective inhibitors. Br J Pharmacol. 1992; 106(4):1028-34. PMC: 1907637. DOI: 10.1111/j.1476-5381.1992.tb14451.x. View

Ishiyama Y, Kitamura K, Ichiki Y, Nakamura S, KIDA O, Kangawa K . Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats. Eur J Pharmacol. 1993; 241(2-3):271-3. DOI: 10.1016/0014-2999(93)90214-3. View

Kitamura K, Kangawa K, Kojima M, Ichiki Y, Matsuo H, Eto T . Complete amino acid sequence of porcine adrenomedullin and cloning of cDNA encoding its precursor. FEBS Lett. 1994; 338(3):306-10. DOI: 10.1016/0014-5793(94)80289-0. View

Eguchi S, Hirata Y, Kano H, Sato K, Watanabe Y, Watanabe T . Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells. FEBS Lett. 1994; 340(3):226-30. DOI: 10.1016/0014-5793(94)80143-6. View

ODonnell M, Garippa R, Rinaldi N, Selig W, SIMKO B, Renzetti L . Ro 25-1553: a novel, long-acting vasoactive intestinal peptide agonist. Part I: In vitro and in vivo bronchodilator studies. J Pharmacol Exp Ther. 1994; 270(3):1282-8. View

Kanazawa H, Kurihara N, Hirata K, Kudoh S, Kawaguchi T, Takeda T . Adrenomedullin, a newly discovered hypotensive peptide, is a potent bronchodilator. Biochem Biophys Res Commun. 1994; 205(1):251-4. DOI: 10.1006/bbrc.1994.2657. View

Santing R, Olymulder C, Van der Molen K, Meurs H, Zaagsma J . Phosphodiesterase inhibitors reduce bronchial hyperreactivity and airway inflammation in unrestrained guinea pigs. Eur J Pharmacol. 1995; 275(1):75-82. DOI: 10.1016/0014-2999(94)00749-w. View

Martinez A, Miller M, Unsworth E, Siegfried J, Cuttitta F . Expression of adrenomedullin in normal human lung and in pulmonary tumors. Endocrinology. 1995; 136(9):4099-105. DOI: 10.1210/endo.136.9.7649118. View

10.

Dey R, Shannon Jr W, Said S . Localization of VIP-immunoreactive nerves in airways and pulmonary vessels of dogs, cat, and human subjects. Cell Tissue Res. 1981; 220(2):231-8. DOI: 10.1007/BF00210505. View

11.

Bundgaard A, Enehjelm S, Aggestrup S . Pretreatment of exercise-induced asthma with inhaled vasoactive intestinal peptide (VIP). Eur J Respir Dis Suppl. 1983; 128 (Pt 2):427-9. View

12.

Diamond L, Szarek J, Gillespie M, Altiere R . In vivo bronchodilator activity of vasoactive intestinal peptide in the cat. Am Rev Respir Dis. 1983; 128(5):827-32. DOI: 10.1164/arrd.1983.128.5.827. View

13.

Barnes P, DIXON C . The effect of inhaled vasoactive intestinal peptide on bronchial reactivity to histamine in humans. Am Rev Respir Dis. 1984; 130(2):162-6. DOI: 10.1164/arrd.1984.130.2.162. View

14.

Polak J, Bloom S . Regulatory peptides of the gastrointestinal and respiratory tracts. Arch Int Pharmacodyn Ther. 1986; 280(2 Suppl):16-49. View

15.

Palmer J, Cuss F, Barnes P . VIP and PHM and their role in nonadrenergic inhibitory responses in isolated human airways. J Appl Physiol (1985). 1986; 61(4):1322-8. DOI: 10.1152/jappl.1986.61.4.1322. View

16.

Palmer J, Cuss F, Warren J, Blank M, Bloom S, Barnes P . Effect of infused vasoactive intestinal peptide on airway function in normal subjects. Thorax. 1986; 41(9):663-6. PMC: 460426. DOI: 10.1136/thx.41.9.663. View

17.

Torphy T, Burman M, Huang L, Tucker S . Inhibition of the low km cyclic AMP phosphodiesterase in intact canine trachealis by SK&F 94836: mechanical and biochemical responses. J Pharmacol Exp Ther. 1988; 246(3):843-50. View

18.

Dusser D, Umeno E, Graf P, Djokic T, Borson D, Nadel J . Airway neutral endopeptidase-like enzyme modulates tachykinin-induced bronchoconstriction in vivo. J Appl Physiol (1985). 1988; 65(6):2585-91. DOI: 10.1152/jappl.1988.65.6.2585. View

19.

Torphy T, Undem B, Cieslinski L, Luttmann M, Reeves M, Hay D . Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle. J Pharmacol Exp Ther. 1993; 265(3):1213-23. View